| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 3JL137394Y |
| InChI Key | NCDZABJPWMBMIQ-INIZCTEOSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H33N3O3S |
| Molecular Weight | 419.59 |
| AlogP | 4.34 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 82.53 |
| Molecular species | ACID |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 29.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 2-7 | - | - | - | |
|
Enzyme
|
- | 2-7 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Pituitary ACTH Hypersecretion | 2 | D047748 | ClinicalTrials |
| Pseudotumor Cerebri | 2 | D011559 | ClinicalTrials |
| Ocular Hypertension | 2 | D009798 | ClinicalTrials |
| Obesity | 1 | D009765 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2153191 |
| DrugBank | DB14875 |
| EPA CompTox | DTXSID80145044 |
| FDA SRS | 3JL137394Y |
| Guide to Pharmacology | 7695 |
| PDB | 14M |
| PubChem | 24946280 |
| SureChEMBL | SCHEMBL1967349 |
| ZINC | ZINC000095575356 |